Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kalow

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1992
Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6)S V Otton, R F Tyndale, D Wu, et al.
Research Communications in Chemical Pathology and Pharmacology|July 1, 1983
Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage timesM Brackley, G Carro-Ciampi, D J Stewart, et al.
Occupational and Environmental Medicine|February 1, 1995
Induction of P-450 in workers exposed to dioxinW Halperin, W Kalow, M H Sweeney, et al.
Journal of Clinical Psychopharmacology|June 9, 1998
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivoV Ozdemir, C A Naranjo, R W Shulman, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertralineV Ozdemir, C A Naranjo, N Herrmann, et al.
British Journal of Clinical Pharmacology|January 1, 1993
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadoneD Wu, S V Otton, B A Sproule, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Archives of Biochemistry and Biophysics|February 1, 1990
The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteinsH B Niznik, R F Tyndale, F R Sallee, et al.
International Anesthesiology Clinics|January 1, 1979
Contributing authorsB A Britt, F Y Chan, M A Denborough, et al.
Lancet (London, England)|June 1, 1991
Intramuscular desferrioxamine in patients with Alzheimer's diseaseD R Crapper McLachlan, A J Dalton, T P Kruck, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1992
Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6)S V Otton, R F Tyndale, D Wu, et al.
Research Communications in Chemical Pathology and Pharmacology|July 1, 1983
Stability of the paraoxonase phenotyping ratio in collections of human sera with differing storage timesM Brackley, G Carro-Ciampi, D J Stewart, et al.
Occupational and Environmental Medicine|February 1, 1995
Induction of P-450 in workers exposed to dioxinW Halperin, W Kalow, M H Sweeney, et al.
Journal of Clinical Psychopharmacology|June 9, 1998
Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivoV Ozdemir, C A Naranjo, R W Shulman, et al.
Journal of Clinical Psychopharmacology|February 24, 1998
The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertralineV Ozdemir, C A Naranjo, N Herrmann, et al.
British Journal of Clinical Pharmacology|January 1, 1993
Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadoneD Wu, S V Otton, B A Sproule, et al.
Pharmacogenetics|July 18, 2000
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration methodV Ozdemir, W Kalow, B K Tang, et al.
Archives of Biochemistry and Biophysics|February 1, 1990
The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteinsH B Niznik, R F Tyndale, F R Sallee, et al.
International Anesthesiology Clinics|January 1, 1979
Contributing authorsB A Britt, F Y Chan, M A Denborough, et al.
Lancet (London, England)|June 1, 1991
Intramuscular desferrioxamine in patients with Alzheimer's diseaseD R Crapper McLachlan, A J Dalton, T P Kruck, et al.
Pageof 19